Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)
Clinical trial NCT04157088 · TERMINATED
Trial details
- NCT number
- NCT04157088
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-17
- Primary completion
- 2022-07-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.